Onychomycosis is a fungal infection of the fingernails or toenails, wherein the bed of the nail and the plate under the surface of the nail are affected.The global dermatophytic onychomycosis market is driven by rise in prevalence of dermatophytic onychomycosis, increase in geriatric population prone to diabetes, sedentary lifestyle, surge in number of R&D activities, and high demand for aesthetic appearing nails. The key players operating in this market include Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Johnson & Johnson
The key players operating in this market include Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Johnson & Johnson
Get sample copy of this report @ https://www.alliedmarketresearch.com/request-toc-and-sample/4396?utm_source=PC_Diigo